Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin M Segal

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Journal of Clinical Medicine|January 24, 2019
The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal ModelsBenjamin M Segal
Journal of the Neurological Sciences|February 8, 2005
CNS chemokines, cytokines, and dendritic cells in autoimmune demyelinationBenjamin M Segal
Journal of Neuroimmunology|October 2, 2007
The role of natural killer cells in curbing neuroinflammationBenjamin M Segal
European Journal of Immunology|April 28, 2012
The unwavering commitment of regulatory T cells in the suppression of autoimmune encephalomyelitis: another aspect of immune privilege in the CNSBenjamin M Segal
Current Allergy and Asthma Reports|January 25, 2003
Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune diseaseBenjamin M Segal
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 2, 2014
Stage-specific immune dysregulation in multiple sclerosisBenjamin M Segal
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2018
Enhancing natural killer cells is beneficial in multiple sclerosis - CommentaryBenjamin M Segal
Current Opinion in Neurology|April 11, 2013
Neurosarcoidosis: diagnostic approaches and therapeutic strategiesBenjamin M Segal
European Journal of Immunology|July 8, 2009
Getting to the crux of the matter: IL-23 and Th17 cell accumulation in the CNSBenjamin M Segal
Clinical Immunology (Orlando, Fla.)|April 10, 2018
Modulation of the Innate Immune System: A Future Approach to the Treatment of Neurological DiseaseBenjamin M Segal
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Journal of Clinical Medicine|January 24, 2019
The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal ModelsBenjamin M Segal
Journal of the Neurological Sciences|February 8, 2005
CNS chemokines, cytokines, and dendritic cells in autoimmune demyelinationBenjamin M Segal
Journal of Neuroimmunology|October 2, 2007
The role of natural killer cells in curbing neuroinflammationBenjamin M Segal
European Journal of Immunology|April 28, 2012
The unwavering commitment of regulatory T cells in the suppression of autoimmune encephalomyelitis: another aspect of immune privilege in the CNSBenjamin M Segal
Current Allergy and Asthma Reports|January 25, 2003
Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune diseaseBenjamin M Segal
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 2, 2014
Stage-specific immune dysregulation in multiple sclerosisBenjamin M Segal
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2018
Enhancing natural killer cells is beneficial in multiple sclerosis - CommentaryBenjamin M Segal
Current Opinion in Neurology|April 11, 2013
Neurosarcoidosis: diagnostic approaches and therapeutic strategiesBenjamin M Segal
European Journal of Immunology|July 8, 2009
Getting to the crux of the matter: IL-23 and Th17 cell accumulation in the CNSBenjamin M Segal
Clinical Immunology (Orlando, Fla.)|April 10, 2018
Modulation of the Innate Immune System: A Future Approach to the Treatment of Neurological DiseaseBenjamin M Segal
Pageof 10